About Medivisor Inc.:
Medivisor is a medical communications company dedicated to providing concise and timely medical information to healthcare industry professionals. Medivisor exclusively serves the bioscience and pharmaceutical markets, offering specialized medical marketing consulting, graphic design, web site marketing strategy and market research.

About Cura Pharmaceutical: Cura is a privately held pharmaceutical business that develops, distributes and sells innovative and generic pharmaceuticals. It focuses on selected niche specialty markets through the offering of distinctive products and services, which provide distinct unmet medical needs.

About Mucotrol(TM): Mucotrol(TM) is prescribed for the management and relief of pain for Mucositis, which may be caused by chemotherapy or radiotherapy and irritation due to oral surgery. The National Cancer Institute estimates that approximately 300,000 cancer patients in the U.S. suffer from mucositis associated with cancer treatments.

Medivisor to Acquire Next-Gen Media Agency
HUNTINGTON STATION, NY, Jul 10, 2007 (MARKET WIRE via COMTEX) -- Medivisor, Inc. (PINKSHEETS: MVSR), a leader in next-generation marketing tools, today announced that it has entered into a definitive agreement to acquire Big Pants Media LLC, a privately held New York-based design and development agency, in an all-stock transaction valued at $85,000 based on Medivisor's closing stock price on June 30, 2007. The acquired businesses and assets will be integrated with Medivisor's existing operations to further enhance the full suite of marketing/promotional tools and services (i.e. SMS capabilities to cell phones, PDAs & Smartphones). In addition, the Big Pants Media acquisition also brings WAP development and application technology offerings to future Medivisor clients.

"On the heels of our recent Mucotrol marketing rights win, we are now executing our expansion plans through strategic alliances and acquisitions to extend our leadership position in online marketing," said Dino Luzzi, Chief Executive Officer of Medivisor. "This key acquisition of Big Pants Media immediately allows Medivisor the opportunity to leverage our own technology to attract a deeper customer base while completely embracing the ever changing landscape of next-generation marketing. Our prior seamless dealings with Big Pants only solidifies this purchase as the next logical step for us."

Based in Hauppauge, NY, Big Pants Media is a full-service design and development agency that develops websites and strategic marketing campaigns across web and mobile. Big Pants Media provides the necessary skill set to successfully research, develop, execute, and optimize the perfect online media mix. Additionally, as delivering content to mobile devices such as cell phones and PDAs becomes more prevalent with consumer adaptation of the mobile internet, Big Pants Media is already positioned to design and deliver custom WAP Sites and SMS Marketing campaigns, having successfully completed several mobile specific projects.

Medivisor Mucotrol release 6.12.07
Huntington Station, NY—June 12, 2007—Medivisor, Inc. (OTCBB: MVSR.PK) today announced the extension of an existing contract with Cura Pharmaceutical Co, Inc. Under the new three-year contract, Medivisor will provide direct to physician marketing for Mucotrol™, used to treat various forms of oral ulcerations such as mucositis and stomatitis. This commission-based agreement with Cura allows for Medivisor to have the “exclusive” marketing rights for Mucotrol™. Furthermore, Cura and Medivisor are also in discussions for other innovative products which Cura intends to market in the USA territory.

“Medivisor is delighted to extend our relationship with Cura Pharmaceutical Co. Inc. With the exclusive rights to provide marketing to the healthcare industry and leveraging the e-Challenge program for Mucotrol™, we look forward to this mutually beneficial partnership. As a result, Medivisor will now be able to execute our growth strategy and continue to provide the Pharmaceutical Industry with targeted digital marketing,” says Dino Luzzi, Chief Executive Officer of Medivisor Inc.

About Mucotrol™

Mucotrol™ is an oral gel wafer that received 510-K approval as a device from the Food and Drug Administration in late November 2004, as a treatment for mouth sores related to chemotherapy. Mucotrol™ has a mechanical action indicated for the management and relief of pain by adhering to the mucosal surface of the mouth and soothing oral lesions of various origins including oral mucositis/stomatitis, which may be caused by chemotherapy or radiotherapy, irritation due to oral surgery and traumatic ulcers caused by braces or ill fitting dentures or diseases. Mucositis is a painful inflammation of the mucosa of the mouth. The National Cancer Institute estimates that approximately 300,000 cancer patients in the U.S. suffer from mucositis associated with cancer treatments.
About Cura Pharmaceutical Co, Inc.

Cura Pharmaceutical Co Inc. is a privately held new pharmaceutical business that develops, distributes and sells innovative and generic pharmaceuticals. Cura feels that as a smaller specialized pharmaceutical company with an experienced executive team it can focus on disease states and/or therapies that, for various reasons, that have not yet been addressed. Cura will focus its corporate energy to provide products that are; “medically necessary” yet not available in the U.S.A., contain ingredients that are difficult to develop or produce, are constantly in short supply, and that are suitable for only a small patient population. For more about Cura go to http://www.curapharma.com.

Aug 2006 Medivisor enters Media Partnership Agreement with ACI Communications
Active Communications International, Inc. (ACI) is a leader in conference planning and production. ACI produces world-class events in many business segments including Cardiac Services, Women's Health, Neuroscience, Sports Medicine and Orthopedic Services. Together, Medivisor and ACI's combined media power has the potential to reach thousands of online Physicians for the upcoming Adding, Updating and Expanding Competitive Bariatric Surgery Services

Click here for more details.

Medivisor Inc. and Cura Pharmaceutical Sign Marketing Agreement for Mucotrol™

Huntington Station, NY., February 28, 2006 – announced today that it has entered into a marketing agreement with Cura Pharmaceutical Co., Inc., a New Jersey based pharmaceutical marketing company, to distribute, promote and sell Mucotrol™ concentrated oral gel wafer for the management and relief of pain from oral lesions associated with oral mucositis/stomatitis in the United States. According to the terms of the agreement, Cura will distribute and sell Mucotrol(TM) while Medivisor will market the product. Dino Luzzi, Medivisor's CEO, commented: "We are excited by the potential of this agreement. Cura's management has extensive experience in the oncology market and has achieved significant market share in the products it has introduced. Medivisor’s marketing plan calls to leverage its expertise to market Mucotrol™ to hospitals with major oncology centers across the country as well as larger private oncology practices and other secondary markets."

The National Cancer Institute estimates that approximately 300,000 cancer patients in the United States suffer from mucositis associated with cancer treatments.

About Cura Pharmceutical Co.
Cura Pharmaceutical Co., Inc. is a New Jersey based pharmaceutical marketing company that focuses in selected niche specialty markets through the offering of distinctive products and services, which provide distinct unmet medical needs, efficiency and/or cost effectiveness, products not readily accessible, as well as products that enhance existing treatments.

Medivisor's Internet Conferencing joins the fight against cancer. Medivisor hosted participation of the 2004 International Conference on Cancer on the Internet.

The Internet is the cornerstone of the techno-cultural revolution that is starting to transform the nature of cancer control. Patients have been at the forefront of this revolution and many are now regularly using the Internet to obtain information about their disease and its treatment, seek support from on-line patient communities and support groups, share knowledge and experiences with other patients and to communicate with their professional carers and loved ones. There is a great deal of confusion and many concerns as to the quality and appropriateness of online patient resources; however, it is impossible to police the Internet. In order to address these concerns, many governmental and non-governmental organizations have developed guidelines for quality health Websites and on evaluating health information on the Internet. Unfortunately, implementation of these guidelines has been patchy. Moreover, there is little or no government protection for e-consumers of health sites particularly in terms of privacy, security and confidentiality.

The Internet provides an important tool to facilitate clinical practice and cancer research. Professional access to and use of content and Internet applications is an essential part of providing appropriate cancer care, for more information, please register at Statdose.com

PAST EVENTS :

2004 International Conference on Cancer on the Internet
September 13-14, 2004
Rockefeller University, New York City

Organized by the European School of Oncology and the
American-Italian Cancer Foundation

Online participation facilitated by Medivisor | www.medivisor.com | Click for 2004 Program For a free cd-rom copy of the 2004 conference please email: cbush@medivisor.com

ASTRO's 49th Annual Meeting
October 28 - November 1, 2007
Los Angeles Convention Center
ASTRO’s Annual Meeting is the premier scientific meeting in radiation oncology and is designed to address the educational needs of radiation oncologists, physicists, biologists, nurses and other healthcare professionals involved in the field of radiation oncology, as well as oncologists working in related specialties.
Medivisor with Cura Pharmaceutical, exhibited Oct. 28 - Oct.31.

American Society of Nephrology
40th Annual Meeting & Scientific Exposition/Renal Week
October 31- November 5, 2007
Moscone Center San Francisco, California
The American Society of Nephrology (ASN) is organized and operated exclusively for scientific and educational purposes enhancing the field of nephrology.
Medivisor with Cura Pharmaceutical, exhibited November 2 – 4, 2007